The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knickelbein, J. E.
Right arrow Articles by Kane, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knickelbein, J. E.
Right arrow Articles by Kane, L. P.
The Journal of Immunology, 2006, 177: 4966-4970.
Copyright © 2006 by The American Association of Immunologists, Inc.


CUTTING EDGE

Cutting Edge: Inhibition of T Cell Activation by TIM-21

Jared E. Knickelbein2, Anjali J. de Souza2, Richard Tosti, Preeti Narayan and Lawrence P. Kane3

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261

T cell Ig and mucin domain protein 2 (TIM-2) has been shown to regulate T cell activation in vitro and T cell-mediated disease in vivo. However, it is still not clear whether TIM-2 acts mainly to augment T cell function or to inhibit it. We have directly examined the function of TIM-2 in murine and human T cell lines. Our results indicate that expression of TIM-2 significantly impairs the induction of NFAT and AP-1 transcriptional reporters by not only TCR ligation but also by the pharmacological stimuli PMA and ionomycin. This does not appear to be due to a general effect on cell viability, and the block in NFAT activation can be bypassed by expression of activated alleles of Ras or calcineurin, or MEK kinase, in the case of AP-1. Thus, our data are consistent with a model whereby TIM-2 inhibits T cell activation.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by start-up funds from the University of Pittsburgh School of Medicine (to L.P.K.).

2 J.E.K. and A.J.D. contributed equally.

3 Address correspondence and reprint requests to Dr. Lawrence P. Kane, Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261. E-mail address: lkane{at}pitt.edu

4 Abbreviations used in this paper: TIM, T cell Ig and mucin domain; MEKK, MEK kinase; PKC, protein kinase C.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Rodriguez-Manzanet, J. H. Meyers, S. Balasubramanian, J. Slavik, N. Kassam, V. Dardalhon, E. A. Greenfield, A. C. Anderson, R. A. Sobel, D. A. Hafler, et al.
TIM-4 Expressed on APCs Induces T Cell Expansion and Survival
J. Immunol., April 1, 2008; 180(7): 4706 - 4713.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. L. Binne, M. L. Scott, and P. D. Rennert
Human TIM-1 Associates with the TCR Complex and Up-Regulates T Cell Activation Signals
J. Immunol., April 1, 2007; 178(7): 4342 - 4350.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.